Measurement of subclinical atherosclerosis: beyond risk factor assessment

被引:30
|
作者
Bisoendial, RJ
Hovingh, GK
de Groot, E
Kastelein, JJP
Lansberg, PJ
Stroes, ESG
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Core Lab Cardiovasc Imaging, NL-1105 AZ Amsterdam, Netherlands
关键词
subclinical atherosclerosis; surrogate end-points; prevention; cardiovascular disease; risk factor management;
D O I
10.1097/00041433-200212000-00002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review Assessment of subclinical atherosclerosis using the current available noninvasive imaging modalities holds promise for individual cardiovascular risk management and monitoring efficacy of therapeutic interventions (i.e. surrogate end-points). The present review addresses benefits and limitations of flow-mediated dilatation, intima-media thickness, electron-beam computed tomography and magnetic resonance coronary angiography. Recent findings Both carotid intima-media thickness and peripheral flow-mediated dilatation correlate inversely with cardiovascular risk factors and coronary artery disease. They have been shown to carry predictive value for future cardiovascular events, but clinical application of both intima-media thickness and flow-mediated dilatation demands further methodological maturation of these techniques. Intima thickening has been successfully targeted in numerous intervention trials, but determination of an explicit threshold value beyond which cardiovascular risk significantly increases will facilitate its utility as a routine clinical tool. Electron-beam computed tomography can accurately detect and quantify coronary artery calcification (an established marker of the total coronary plaque burden). However, lack of evidence of its additional predictive power for future coronary events warrants for further research. Finally, magnetic resonance coronary angiography appears to be a promising technique, integrating both functional and anatomical aspects of coronary artery disease. Properly designed studies are needed to determine its value in clinical practice. Summary Various noninvasive imaging techniques have recently emerged that may find applications in clinical research. However, before widespread clinical utilization, further technical refinement of all of the cited imaging modalities is mandatory. It will be a challenge over the coming few years to clarify whether improvements in surrogate end-points can directly be translated into improved outcomes.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 50 条
  • [41] Assessment of Subclinical Atherosclerosis in Vitamin D Deficiency
    Aydin, Elcin
    Altin, Cihan
    Soylev, Gozde Ozcan
    Tekindal, Mustafa Agah
    Agildere, Muhtesem
    ULTRASOUND QUARTERLY, 2019, 35 (02) : 142 - 146
  • [42] Validated methods for assessment of subclinical atherosclerosis in rheumatology
    György Kerekes
    Pál Soltész
    Michael T. Nurmohamed
    Miguel A. Gonzalez-Gay
    Maurizio Turiel
    Edit Végh
    Yehuda Shoenfeld
    Iain McInnes
    Zoltán Szekanecz
    Nature Reviews Rheumatology, 2012, 8 : 224 - 234
  • [43] Noninvasive assessment of subclinical atherosclerosis in patients with rosacea
    Gurel, Gulhan
    Turan, Yasar
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (01) : 51 - 56
  • [44] Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents
    Thijssen, Dick H. J.
    Cable, N. Timothy
    Green, Daniel J.
    HYPERTENSION, 2010, 55 (03) : E14 - E14
  • [45] Assessment of plasma ceramides as predictor for subclinical atherosclerosis
    Mishra, Pashupati P.
    Mishra, Binisha H.
    Lyytikainen, Leo-Pekka
    Hilvo, Mika
    Juonala, Markus
    Kahonen, Mika
    Hutri-Kahonen, Nina
    Fotiadis, Dimitrios, I
    Raitakari, Olli T.
    Laaksonen, Reijo
    Lehtimaki, Terho
    ATHEROSCLEROSIS PLUS, 2021, 45 : 25 - 31
  • [46] Impact of cardiovascular risk factors on subclinical carotid atherosclerosis in a general population stratified by framingham risk assessment
    Li, Yan
    Liu, Jing
    Wang, Wei
    Wang, Miao
    Qi, Yue
    Qin, Lan-ping
    Zhao, Fan
    Zhao, Dong
    CIRCULATION, 2012, 125 (19) : E895 - E895
  • [47] Uncovering Subclinical Atherosclerosis: Assessment of Low-Attenuation Plaques in Low Risk Group
    Erbay, Muhammed I.
    Susarla, Shriraj
    Lee, Duo
    Pourafkari, Leili
    Kinninger, April
    Bagheri, Marziyeh
    Hamidi, Hossein
    Khan, Muneeb A.
    Bishay, Rachelle N.
    Budoff, Matthew J.
    JACC-CARDIOVASCULAR IMAGING, 2024, 17 (09) : 1116 - 1117
  • [48] Family history of diabetes and the risk of subclinical atherosclerosis
    Park, G. -M.
    Cho, Y. -R.
    Lee, S. -W.
    Yun, S. -C.
    Gil, E. H.
    Kim, D. W.
    Kim, T. -S.
    Kim, C. J.
    Cho, J. S.
    Park, M. -W.
    Her, S. H.
    Kim, Y. -H.
    Yang, D. H.
    Kang, J. -W.
    Lim, T. -H.
    Jung, C. H.
    Koh, E. H.
    Lee, W. J.
    Kim, M. -S.
    Lee, K. -U.
    Kim, H. -K.
    Choe, J.
    Park, J. -Y.
    DIABETES & METABOLISM, 2016, 42 (03) : 170 - 177
  • [49] Genetic predisposition to obesity and risk of subclinical atherosclerosis
    Shi, Juan
    Hong, Jie
    Qi, Lu
    Cui, Bin
    Gu, Weiqiong
    Zhang, Yifei
    Li, Lijuan
    Miao, Lin
    Wang, Rui
    Wang, Weiqing
    Ning, Guang
    GENE, 2014, 549 (02) : 223 - 227
  • [50] Imaging subclinical atherosclerosis in cardiovascular risk stratification
    Kozakova, Michaela
    Palombo, Carlo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (03) : 247 - 249